for Veterans and the Public
Chronic Hepatitis C Virus (HCV) Infection: Treatment Considerations
For the full PDF version, click here
This revision (December 15, 2015) incorporates updates to preferred regimens for cirrhotic patients with chronic hepatitis C virus (HCV) genotype 1b infection, and those with genotype 2 or genotype 3 infection. Additional revisions include updates on drug-drug interactions to provide clinicians with guidance on the concomitant use of HCV drugs and other drugs, including HIV antiretroviral agents (Appendix A, Tables A4 and A5). Information on HCV resistance genotyping has been included (Appendix B). The Panel continues to recommend that HIV/HCV-coinfected patients receive the same HCV antiviral regimen as HCV-monoinfected patients.